Wockhardt profitability ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Returns
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
4.6%4.6%−1.2%−13.8%−15.5%
2.4%2.4%−0.7%−6.2%−7.8%
6.5%6.5%3.2%−4.0%−3.5%
7.2%5.2%2.9%−3.5%−2.7%
Margins
21.7%19.3%13.1%1.4%3.8%
12.6%12.6%5.8%−6.6%−5.7%
—69.0%168.2%−23.1%—
13.0%7.1%−0.5%−15.0%−23.5%
11.6%5.9%−1.9%−16.9%−23.4%
11.5%6.3%−1.6%−16.5%−21.1%
7.5%7.5%−3.9%5.7%4.2%
Additional
10.6%16.4%−256.3%−12.4%0.5%
4.6%4.6%−1.2%−13.8%−15.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

WOCKPHARMA₹1,922.90

Wockhardt Ltd.

· Pharma & Health
₹ CrorePeersBIOCONSYNGENEASTERDMGLANDPPLPHARMACOHANCELALPATHLABNATCOPHARMMcap ₹31,151 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity-15.52-13.79-1.224.584.58
Return on Assets-7.80-6.16-0.722.382.38
Return on Capital Employed-3.53-4.043.216.506.50
Return on Invested Capital-2.73-3.492.945.247.20
Margins
EBITDA Margin3.811.3913.0519.3321.66
Operating Margin-5.66-6.585.8412.6012.60
Incremental Operating Margin—-23.13168.2268.98—
Pretax Margin-23.54-15.01-0.537.0612.99
Net Income Margin-23.43-16.87-1.895.9011.62
Net Income to Common Margin-21.09-16.55-1.566.3111.48
FCF Margin4.195.72-3.857.537.53
Additional
Effective Tax Rate0.48-12.38-256.2516.3910.58
Sustainable Growth Rate-15.52-13.79-1.224.584.58
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.